Digital AI in cancer diagnostics and devices: Where we are, and wher... While it’s only relatively recently that AI became a household term, the technology is already having a major impact on society.
Digital Initial leap of faith inspires today’s fast-growing digital ... Explore how Tufts Center for the Study of Drug Development has spearheaded the growth of digital clinical trials through an initial leap of faith
Digital The faster horses fallacy: Why true innovation starts with c... “If I had asked people what they wanted, they would have said faster horses.” This quote, often linked to Henry Ford (though its authenticity is debated), has become a go-to argument for in
Digital Tech & Trials: Biostats and medical writing There are many outputs produced during a clinical trial, and one of the most crucial is the Clinical Study Report (CSR).
Digital GenAI and the revolution of drug development Bryan Hill, life sciences chief technology officer at Cognizant, discusses how generative AI is revolutionising drug development in a new podcast.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
